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ABSTRACT
The XPA protein functions together with the single-
stranded DNA (ssDNA) binding protein RPA as the
central scaffold to ensure proper positioning of re-
pair factors in multi-protein nucleotide excision re-
pair (NER) machinery. We previously determined the
structure of a short motif in the disordered XPA N-
terminus bound to the RPA32C domain. However, a
second contact between the XPA DNA-binding do-
main (XPA DBD) and the RPA70AB tandem ssDNA-
binding domains, which is likely to influence the
orientation of XPA and RPA on the damaged DNA
substrate, remains poorly characterized. NMR was
used to map the binding interfaces of XPA DBD
and RPA70AB. Combining NMR and X-ray scattering
data with comprehensive docking and refinement re-
vealed how XPA DBD and RPA70AB orient on model
NER DNA substrates. The structural model enabled
design of XPA mutations that inhibit the interaction
with RPA70AB. These mutations decreased activity
in cell-based NER assays, demonstrating the func-
tional importance of XPA DBD–RPA70AB interaction.
Our results inform ongoing controversy about where
XPA is bound within the NER bubble, provide struc-
tural insights into the molecular basis for malfunc-
tion of disease-associated XPA missense mutations,
and contribute to understanding of the structure and
mechanical action of the NER machinery.
INTRODUCTION
Nucleotide excision repair (NER) is a central DNA repair
pathway responsible for removing bulky lesions from the
genome (1,2). Defects in NER result in the genetic disor-
der xeroderma pigmentosum (XP), characterized by extreme
hypersensitivity to sunlight and an >2000-fold increase in
skin cancer (3,4). NER is a highly dynamic process that op-
erates through the sequential assembly and action of >20
proteins at the DNA lesion (Figure 1A). The core NER re-
action occurs only after a lesion has beenmade accessible in
the context of chromatin by the UV-DDB ubiquitin ligase
complex and associated factors. The reaction is initiated by
XPC-RAD23B, which recognizes destabilization induced in
the DNA by a lesion (5). TFIIH is then loaded, likely via
the XPB helicase. The second helicase of TFIIH, XPD, is
thought to track along the damaged strand, leading to the
formation of a DNA bubble structure, until it stalls at the
lesion, which serves to verify the presence of the lesion. The
xeroderma pigmentosum complementation group A (XPA)
protein and replication protein A (RPA) are then recruited
to the damage site in synchrony andwork together as a scaf-
fold to organize the damaged DNA and NER enzymes (6–
8). XPA and RPA are essential for the localization and ac-
tivation of the two NER endonucleases: ERCC1-XPF and
XPG (9,10). RPA binds and protects single-stranded DNA
(ssDNA) on the undamaged strand (11,12). XPA is thought
to interact with the open bubble without direct contact with
the lesion and its position on the bubble has been assigned
alternately to either the 3′ or the 5′ ss-dsDNA junction (13–
15). Understanding the molecular basis for the function of
theXPA-RPA scaffold is of importance given its central role
in organizing and orchestrating the action of the NER ma-
chinery.
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Figure 1. Human NER factors XPA and RPA. (A) Schematic diagram of the NER pre-incision complex. DNA damage is marked with a star on the
substrate. (B) Schematic diagram of the domain structure of human XPA. The XPA DNA binding region, which contains the globular core, is depicted
as an oval. DNA- and RPA-binding residues are indicated below the domain, aligned with the XPA residues involved in each interaction. Both previously
reported sites for RPA70AB interaction with the XPA globular core are marked for clarity. (C) Schematic diagram of the subunit and domain structure of
human RPA heterotrimer. Globular domains are depicted as ovals. All globular domains are OB-folds except for the winged-helix domain RPA32C. (D)
Schematic representation of the spatial organization of RPA domains when bound to ssDNA. The RPA DNA binding apparatus consists of RPA70A,
RPA70B, RPA70C, RPA32D, and RPA14. A ssDNA molecule of ∼40 nts is depicted as a ribbon. The XPA-binding regions are labeled with arcs.
XPA is composed of a central globular domain
(XPA98–219) containing a zinc-binding motif and non-
globular N- and C-terminal domains that contain sites for
interactions with its many partner proteins (9,10,16–22)
(Figure 1B). The DNA-binding domain (DBD) of XPA
was initially assigned to a central globular core within the
construct spanning residues 98–219, but our subsequent
analysis showed that DNA binding requires 20 additional
C-terminal residues (23,24). XPA is understood to bind to
a ss–ds junction in the NER bubble. Studies using bubble
mimics indicated that DNA binding involves a basic cleft
in the globular core and basic residues in the C-terminal
extension (23,25).
RPA is a heterotrimer ofRPA70,RPA32 andRPA14 sub-
units (Figure 1C). The tandem high affinity DNA-binding
domains RPA70AB and the trimer core (composed of the
RPA70C, RPA32D and the core RPA14 domains) consti-
tute the DNA-binding apparatus, which interacts with ss-
DNA in a 5′-3′ orientation (11,26) (Figure 1D). In addition
to functioning to protect and organize ssDNA, RPA serves
to recruit partner proteins to DNA processing machinery
using its RPA70N and RPA32C domains. These domains
are linked to the DNA-binding apparatus by flexible tethers
of ∼70 and ∼35 residues, respectively. Hence, interactions
with these two domains will not significantly influence the
orientation of RPA and partner proteins on their DNA sub-
strate. Importantly, in addition to binding to RPA32C or
RPA70N, functionally relevant interactions withRPA70AB
have been reported for a number of partner proteins (27,28).
The binding of XPA to RPA is one such example of an
interaction involving two points of contact. The RPA32C
domain binds a short motif (XPA29–46) in the disordered
XPA N-terminal domain (19,29). The second contact oc-
curs between RPA70AB and the XPA globular core. While
the XPA29–46–RPA32C interaction is of higher affinity, it
is likely that the XPA DBD–RPA70AB interaction plays a
more significant role in the positioning of XPA and RPA on
the NER bubble since they both bind the substrate in addi-
tion to each other. Published studies of where RPA70AB
contacts XPA are not consistent with each other (30–33).
NMR titrations of XPA98–219 with truncated RPA70 con-
structs (and in the absence of DNA) suggested that the
interaction is mediated by the zinc-binding motif in the
N-terminal portion of XPA98–219 (18,31). In contrast, bio-
chemical pull-down and cell-free NER assays with XPA
mutants suggested that residues at the C-terminal end of
XPA98–219 are responsible for interaction with RPA70AB
(33,34).
Our long-term objective is to understand the functional
relevance and physical basis for howXPA and RPA serve as
scaffolds for the NER machinery. We believe that the inter-
action between XPA DBD and RPA70AB is critical to the
positioning of these proteins on the NER bubble and report
here a detailed structural analysis of the complexes of XPA
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DBD and RPA70AB bound to model NER bubble sub-
strates mimicking the 3′ and 5′ ss–ds junctions. NMR spec-
troscopy was used to map the interaction surfaces on the
two proteins. These NMR data along with SAXS data for
the complex were used as restraints for docking and refine-
ment of the 3Dmodels of the XPADBD–DNA–RPA70AB
ternary complexes. Structure-basedmutationswere then de-
signed to enable functional analysis of this XPA–RPA con-
tact. XPAmutants with reduced affinity for RPA70ABwere
defective in repair of 1,3-cisplatin intrastrand crosslinks.
These results show that the XPA DBD–RPA70AB contact
is required for the maintenance of NER activity.
MATERIALS AND METHODS
Bacterial expression vectors
We have previously reported the construction and purifica-
tion of pBG100-XPAFL, pBG100-XPA98–219 and pBG100-
XPA98–239 constructs (23), and of pSV281-RPA70AB
(RPA70181–422) (35). Site-directed mutagenesis for pBG100-
XPA98–239 and pBG100-XPAFL E106K and pBG100-
XPA98–239 F112A was performed using the Q5(R) Site-
Directed Mutagenesis Kit Quick Protocol (E0554, New
England Biolabs) and the following primers:
E106K F: 5′-TGTAATATGCAAAGAATGTGGG-3′;
E106K R: 5′-TAATCAAATTCCATAACAGGTC-3′,
F112A F: 5′-TGGGAAAGAAGCTATGGATTCTTATC
TTATG-3′;
F112A R: 5′-CATTCTTCGCATATTACATAATC-3′.
Vectors for pBG100-XPA98–239 and pBG100-
XPAFL M2 (E106K/F112A) and M6
(D101N/E106K/K110E/E111K/F112A/D114N) mu-
tants were prepared by the core facility of the Structural
Biology of DNA Repair Machinery Program using the
NEB’s Q5 site-directed mutagenesis kit.
• Primers used were:
XPA-M2 F: 5′-TGGGAAAGAAGCTATGGATTCT
TATCTTATG-3′,
XPA-M2 R: 5′- CATTCTTTGCATATTACATAATC-
3′,
XPA-FL-M6 F: 5′- AGAATGTGGGGAGGAAGCTA
TGG-3′,
XPA-FL-M6 R: 5′- TTGCATATTACATAGTTAAA
TTCC-3′,
XPA-DBD-M6 F: 5′- AGAATGTGGGGAGAAAGC
TATGAAC-3′,
XPA-DBD-M6 R: 5′- TTGCATATTACATAGTTAAA
TTC-3′.
and were shared within the SBDR consortium.
DNA substrates
Supplementary Figure S1 shows the structures of the
DNA substrates used in this study. Desalted oligodeoxynu-
cleotides were purchased from Sigma-Aldrich Co. Splayed-
arm dsDNA substrates were prepared by mixing an
equimolar amount at 1 mM of each strand in the duplex
annealing buffer (60 mM KCl, 6 mM Tris pH 7.5, 0.2
mM MgCl2). The mixture was then heated to 95◦C in a
thermoblock and allowed to cool to room temperature for
annealing. Hairpin-containing DNA substrates, including
those that were fluorescein-labeled, were dissolved in the
same buffer at 2Mconcentration and annealed by heating
at 95◦C in a thermoblock, followed by immediate cooling on
ice.
Protein expression and purification
Unlabeled and uniformly 15N-enriched human XPA98–219
and XPA98–239 were expressed and purified as described
previously (23) with some modifications to the protocol.
First, 10 MZnCl2 was added during inoculation with the
overnight small-scale culture of the XPA construct to im-
prove the solubility. A Heparin column (GE Healthcare)
purification step was incorporated after the Ni affinity step.
After the nickel column, proteins were dialyzed overnight
against heparin loading buffer (20mMTris pH 7.5, 150mM
NaCl, 10% glycerol, 1 mM DTT), loaded on the heparin
column (5 ml; GE Healthcare), washed with 5–10 column
volumes (CV) of heparin loading buffer and eluted with
a 0–100% gradient of 5 CV of heparin elution buffer (20
mM Tris pH 7.5, 1 M NaCl, 10% glycerol, 1 mM DTT).
RPA70AB was produced following the same protocol as
that for theXPA constructs, except that noZnCl2 was added
to the overnight preculture and TEV protease was used for
His-tag cleavage.
Assessment of formation of the XPADBD–DNA–RPA70AB
ternary complex
In order to test the formation and stability of the ternary
complexes, purified XPA98–239 and RPA70AB proteins were
mixed in an equimolar ratio with theDNA substrates at a fi-
nal concentration of 50–100 M. Analytical size-exclusion
chromatography coupled to multi-angle light scattering
(DAWN HELEOS, Wyatt Technology) (SEC-MALS) was
used to monitor the system. A 24 ml Superdex 75 Increase
analytical gel filtration column (GE Healthcare) was used
with a flow rate of 0.5 ml/min in a buffer containing 20 mM
Tris pH 7.5, 150 mM NaCl, 10% glycerol and 1 mM DTT.
ASTRA software (Wyatt Technologies) was used for data
processing, average molecular mass calculation and estima-
tion of the peak monodispersity. To assess stoichiometry,
fractions were collected and analyzed by SDS-PAGE.
Nuclear magnetic resonance (NMR) spectroscopy
All samples for titrations were concentrated to 50 M in
a buffer containing 20 mM Tris, pH 7.0, 150 mM KCl, 1
mMTris(2-carboxyethyl) phosphine (TCEP) and 5% 2H2O.
Multi-point titrations were performed by preparing two
identical solutions of protein, one with no DNA substrate
and the other at the highest ratio of DNA substrate to
15N-enriched protein, then collecting spectra for these and
intermediate ratios created by mixing of the two solu-
tions. Two-point titrations in the presence of ssDNA were
performed by preparing three identical solutions of 15N-
enriched protein: (i) 15N-enriched protein alone, (ii) 15N-
enriched protein with an equimolar amount of ssDNA, (iii)
15N-enriched protein with an equimolar amount of ssDNA
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and a 4-fold molar excess of the partner protein. After ac-
quisition of all three individual spectra, intermediate ra-
tios of 15N-enriched and unlabeled proteins were made by
mixing samples (ii) and (iii). 15N-1H TROSY-HSQC spec-
tra were recorded in 3-mm tubes at 25◦C using a Bruker
AVANCE 900MHz spectrometer equipped with a TCI cry-
oprobe. Further data processing and analysis were carried
out using SPARKY (36). All residues whose cross peaks
disappeared due to intermediate exchange line broadening
upon binding DNA were placed in the category of signifi-
cantly perturbed. For residues exhibiting chemical shift per-
turbations in fast exchange, we calculated the change in
chemical shift (δ) from the spectra acquired with no sub-
strate and at the highest substrate ratio using the formula:
δ = √[(Ha - Hb)2 + (0.2*(Na - Nb))2]. The threshold for
significant chemical shift perturbation was set to the aver-
ageδ ± 1 or 1.5 standard deviation depending on the rela-
tive sensitivity of the spectrum. Resonance assignments for
XPA98–219, XPA98–239, RPA70AB and RPA70AB–ssDNA
used in the study are available at the BMRB under acces-
sion codes 4249, 27131, 5823 and 50121, respectively.
For a comparison of chemical shift perturbations caused
by the wild-type and mutant XPA proteins, one-point titra-
tions were performed in the presence of DNA substrate
under identical conditions to those described above. Sam-
ples were prepared with 15N-enriched RPA70AB protein at
50 M concentration with an equimolar amount of DNA
and in the absence or presence of a 4-fold molar excess of
unlabeled XPA (WT, M2 or M6). 15N-1H TROSY-HSQC
experiments were acquired with 32 scans, and 2048 and
256 points in direct and indirect dimensions, respectively.
Data processing was carried out using Topspin version 3.2
( C©Bruker Biospin) or Spectra analysis (Ccpnmr version 2.4)
(37).
Small-angle X-ray scattering (SAXS)
The SAXS profiles for the XPA DBD–DNA–RPA70AB
complex were collected in SEC-SAXS mode at the ALS
beamline 12.3.1 LBNLBerkeley, California (38). The X-ray
wavelength λ was 1.03 A˚ and the sample-to-detector dis-
tance was set to 1.5m resulting in scattering vectors, q, rang-
ing from 0.01 to 0.5 A˚−1. The scattering vector is defined as
q = 4 sin/λ, where 2 is the scattering angle. All experi-
ments were performed at 20◦C (39) and data were processed
as described (40). Briefly, the flow through SAXS cell was di-
rectly coupled with an online Agilent 1260 Infinity HPLC
system using a ShodexKW803 column (Shodex™). The col-
umn was equilibrated with running buffer (20 mM Tris pH
7.5, 150 mM NaCl, 2% glycerol, 1 mM DTT) with a flow
rate of 0.5ml/min. A 50l sample was run through the SEC
and 3.0-s X-ray exposures were collected continuously dur-
ing a ∼35 min elution. The SAXS frames recorded prior to
the protein elution peak were used as buffer blanks to sub-
tract from all other frames. The subtracted frames were ex-
amined by radius of gyration (RG) and scattering intensity
at q = 0 A˚−1 (I(0)), derived using the Guinier approxima-
tion I(q) = I(0) exp(-q2RG2/3) with the limits qRG <1.5).
I(0) and RG values were compared for each collected SAXS
curve (frame) across the entire elution peak (Supplemen-
tary Figure S2A). The elution peak was mapped by plotting
the scattering intensity at q = 0 A˚−1 (I(0)), relative to the
recorded frame. Uniform RG values across an XPA DBD–
DNA–RPA70AB elution peak represented a homogenous
assembly (Supplementary Figure S2A). The merged exper-
imental SAXS data were additionally investigated for ag-
gregation by inspecting Guinier plots (Supplementary Fig-
ure S2B). The program SCA˚TTER 3.1 was used to com-
pute the distance distribution, P(r) (Supplementary Figure
S2E). The distance rwhere P(r) approaches zero intensity is
termed theDmax of themolecule.P(r) was normalized based
on molecular mass (55 kDa) determined by SAXS of as-
semblies as calculated by SCA˚TTER as described (41). The
differences in the scattering power of protein and DNA
were not taken into account in the determination of molec-
ular mass because the contribution of DNA to the total is
much less than that of protein. The SAXS data have been
deposited in the SASBDB databank under accession code
SASDH44 for the complex with the 3′ junction substrate
and SADH54 for the 5′ junction substrate.
Structure calculations
The structural models of XPA98–239 in complex with
RPA70AB and the twomodel NERbubbleDNA substrates
were generated in four steps. First, a homologymodel of hu-
man XPA102–214 bound to double-stranded DNA was gen-
erated using the X-ray crystal structure of Saccharomyces
cerevisiae Rad14 (PDB: 5A39) as a template in Modeller
9.19 (42). Five models were created based on the template
of one subunit from the dimer present in the Rad14 crys-
tal structure. Model variance was minimal, and the best
scoring model was chosen for further work. The C-terminal
residues 215–239 were added using the RosettaRemodel ap-
plication (43). The conformation of these residues wasmod-
eled based on analysis of the sequence using the prediction
server Jpred (44), which found very high probability of he-
lical structure for residues 215–231 and predicted residues
232–239 to be in a loop conformation. One thousand mod-
els were generated and the ten best scoring models analyzed
and compared. The model that best matched the predicted
secondary structure and had the best Rosetta score was cho-
sen for further calculations. TheN-terminal residues 98–101
were added by manual building using the Chimera Build
Structure tool. Then the entire set of coordinates was en-
ergy minimized using the Relax application in Rosetta 3.9
(45).
The next step was to adjust the DNA in the XPA DBD
model to match the experimental substrate, since the se-
quence was different and the DNA duplex is perturbed by a
cisplatin crosslink. This involved docking an ideal 10 base-
pair B-DNA double helix using the HADDOCK2.2 web
server (46). The active residues for XPAwere selected based
on the NMR chemical shift perturbations reported else-
where (25) and a solvent accessible surface area >50%. A
total of 1000 models were initially generated, and the best
scoring 200 were used in the subsequent refinement. Based
on the recommended HADDOCK protocol, the refined
models were clustered, and the best scoring model of the
best scoring cluster was chosen as the representative struc-
ture for subsequent refinements.
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The third stepwas docking theXPADBD–dsDNA struc-
ture and the X-ray crystal structure of RPA70AB in com-
plex with d-C8 (PDB: 1JMC). To ensure the results were ac-
curate, this step was performed using HADDOCK (HAD-
DOCK2.2 web server) with the NMR data to drive the gen-
eration of the initial models, which were then assessed based
on fit to the SAXS data. To ensure the two DNAmolecules
were within the distance range required for connecting the
two sub-complexes with the four-nucleotide linker that was
present in the experimental samples, a special distance re-
straint of 20 ± 3 A˚ was included in these docking calcula-
tions. It was here that the calculations for the twoNER sub-
strates diverged. For the 3′ junction substrate, the restraint
was set between the 3′ end of the DNA bound to XPADBD
and the 5′ end of the DNA bound to RPA. For the 5′ junc-
tion substrate, the restraint was set between the 5′ end of
the DNA bound to XPA DBD and the 3′ end of the DNA
bound to RPA. Active residues for both proteins were de-
fined as those exhibiting statistically significant NMRCSPs
or line broadening and a solvent accessible surface area
>50%. Of the total of 1000 models initially generated, the
top 200were refined inHADDOCKwith an explicit solvent
layer of 8 A˚ and then clustered based on their structural sim-
ilarity. Next, a theoretical scattering profile was calculated
for best scoring structure in each cluster, then compared to
the experimental scattering profile using FoXS (47,48). This
confirmed that the best scoring clusters gave reasonable fits
to the SAXS data.
To complete the generation of the structural model,
the four missing nucleotides in the DNA substrate were
built in using the Rosetta stepwise application (49). The
theoretical scattering profile was then re-calculated for
all structures in the best HADDOCK-scoring clusters
(three for the 3′ junction model and two for the 5′ junction
model) and compared to the experimental scattering
profile (Supplementary Table S1). The fit to the data was
qualitatively analyzed by superimposing the structure onto
a molecular envelope that was created using DAMMIN
in SCA˚TTER 3.1. The superimpositions were carried out
using SUPCOMB (50). In both cases, it turned out that
the best HADDOCK-scoring clusters had the lowest 
fit to the scattering curve. The best HADDOCK-scoring
structure was selected as the best representative of the
respective RPA70AB-XPA DBD–DNA complex. The
structures were analyzed using the PROCHECK server
(http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/
pdbsum/GetPage.pl?pdbcode=index.html; Supplementary
Materials and Supplementary Table S2). The coordinates
for the representative structures have been deposited
in the PDB-DEV databank under accession codes PDB-
DEV 00000039 and PDBDEV 00000040 for the 3′ junction
and 5′ junction substrate complexes, respectively.
Circular dichroism (CD) spectroscopy
Samples of XPA DBD were exchanged into a 150 mM
K2HPO4 (pH 7.5) buffer, diluted to a concentration of 0.1
mg/ml (5.6 M), and passed through a 0.2-m filter. The
far-UV CD spectrum over the range 190–260 nm was ac-
quired at room temperature using a Jasco J-810 spectropho-
tometer. Each spectrum is the average of three scans ac-
quired with a scanning rate of 50 nm/min and data pitch of
1 nm. Prior to generating the overlay, the XPA DBD wild-
type and mutant proteins spectra were exported to an Excel
spreadsheet, buffer subtracted and plotted.
Microscale thermophoresis (MST)
For measurements of DNA-binding affinity by MST,
all proteins were transferred into MST buffer (50 mM
Tris-HCl, pH 7.8, 150 mM NaCl, 10 mM MgCl2,
0.05% Tween20 and 1 mM DTT). The experiments
were performed with a 5′-FAM DNA substrate (5′-
TTTTGCGGCCGCTTTTGCGGCCGC-3′) (25) with a 4
nt hairpin to stabilize the 8 bp duplex. The substrate was an-
nealed by heating to 95◦C in a thermoblock, followed by im-
mediate cooling on ice. A fluorescein-labeled DNA stock (2
M) was diluted in a buffer containing 60 mMKCl, 6 mM
Tris pH 7.5 and 0.2 mM MgCl2 to a concentration of 440
nM. A series of 16 dilutions of the protein were prepared at
varying concentrations, all with a DNA concentration of 40
nM. All experiments were carried out in standard capillar-
ies at room temperature at 20% LED power and 40% MST
power. Final KD values were calculated using MO.Affinity
software (NanoTemper, Inc.).
Electrophoretic mobility shift assay (EMSA)
EMSA of full-length XPA binding to DNA three-way junc-
tions was carried out as described previously (9). The la-
beled 5′-FAM oligonucleotide was annealed with a 2-fold
excess of the two unlabeled oligonucleotides
FAM-5′-GTTCGTCAGGATTCCAATTCGTGCAGGC
AT
-3′,
5′-ATGCCTGCACGAATTAAGCCATTCGTAATCAT
GGT-3′,
5′-ACCATGATTACGAATGGCTTGGAATCCTGACG
AAC-3′
in 10 mM Tris-HCl (pH 8.0) and 50 mM NaCl. The an-
nealed oligo was incubated with wild-type or mutant XPA
(0–40 nM) in a 15 l mixture containing 25 mM Tris-HCl
(pH 8.0), 60 mM NaCl, 0.1 mg/ml BSA, 10% glycerol, 1
mM EDTA and 1 mM DTT at 25◦C for 30 min. The reac-
tion mixture was loaded onto a native 8% polyacrylamide
gel pre-equilibrated with 0.5 × TBE buffer and run at 4◦C
for 2 h at 20 mA. Gels were scanned using an Amersham
Typhoon RGB imager. Two independent repetitions were
performed.
In vitro NER activity assay
In vitroNER assays were carried out using extracts derived
from XPA-deficient XP2OS cells and a plasmid contain-
ing a site-specific 1,3-intrastrand cisplatin (cis-Pt) lesion as
described previously (9,51). For each reaction, 2 l of re-
pair buffer (200 mM HEPES-KOH, 25 mM MgCl2, 110
mM phosphocreatine (di-Tris salt, Sigma), 10 mM ATP,
2.5 mM DTT and 1.8 mg/ml BSA, adjusted to pH 7.8),
0.2 l of creatine phosphokinase (2.5 mg/ml, Sigma), 3
l of XPA-deficient cell extract (about 10 mg/ml), NaCl
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(to a final concentration of 70 mM) and 50 nM of puri-
fied wild-type or mutant XPA in a total volume of 9 l
were pre-warmed at 30◦C for 10 min. About 1 l plas-
mid containing cis-Pt (50 ng/l) was added to each re-
action, and the samples were incubated at 30◦C for dif-
ferent incubation times: 0, 5, 10, 20, 45 and 90 min. Af-
ter placing the samples on ice, 0.5 l of 1 M of a 3′-
phophorylated oligonucleotide: (5′-GGGGGAAGAGTG
CACAGAAGAAGACCTGGTCGACCp-3′) was added
and the mixture heated at 95◦C for 5 min. The samples were
allowed to cool down to room temperature for 15 min to al-
low the DNA to anneal. About 1l of a Sequenase/[-32P-
dCTP mix (0.25 units of Sequenase and 2.5 Ci of [-32P]-
dCTP per reaction) was added before incubating at 37◦C for
3 min, followed by addition of 1.2 l of dNTPmix (100 M
of each dATP, dTTP, dGTP; 50 M dCTP) and incubated
for another 12 min. The reactions were stopped by adding
12 l of loading dye (80% formamide/10 mM EDTA) and
heating at 95◦C for 5 min. The samples were run on a 14%
sequencing gel (0.5× TBE) at 45 W for 2.5 h, and the re-
actions products were visualized using a PhosphorImager
(Amersham Typhoon RGB, GE Healthcare Bio-Sciences).
Two independent repetitions were performed.
RESULTS
XPA possesses distinct binding motifs for RPA70AB and
DNA
As noted above, two different models have been proposed
for which region of the XPA DNA-binding domain (DBD)
contacts RPA70AB: the zinc-binding motif (18,31) or the
C-terminal region (33,34). In order to address this discrep-
ancy, we performed a series of detailed analyses of the XPA
and RPA70AB interaction interfaces by 2D heteronuclear
15N-1H NMR. The previously reported studies were per-
formed on XPA98–219, which at the time was understood
to be the DBD. However, since we had previously estab-
lished that the full DNA binding activity required an addi-
tional 20 C-terminal residues, we performed the first titra-
tion with 15N-enriched XPA98–239. The comparison of the
spectra without and with RPA70AB revealed an approxi-
mately equal mixture of fast and intermediate exchange ef-
fects, reflected in chemical shift perturbations (CSPs) and
line broadening (Figure 2A). The effects were observed only
for a subset of resonances indicating these arose from a
specific binding event. Residues that were perturbed in the
titration were mapped on the structure (Figure 2B), which
revealed that binding occurs primarily to the zinc-binding
motif. These observations are consistent with previous stud-
ies that suggested the interaction occurs in this region, but
which were not definitive because no control experiments
were included to compare theXPA98–219 andXPA98–239 con-
structs and in one case the RPA construct was truncated in
the middle of RPA70B (18,31). In the XPA98–239 titration,
no significant effects were observed on residues in the C-
terminal extension. We therefore performed a second titra-
tion with 15N-enriched XPA98–219 (Figure 2C). Comparison
of the effects induced by binding ofRPA70AB in the spectra
of XPA98–239 versus XPA98–219 revealed a similar pattern of
CSPs (cf. Figure 2A–D). This confirms that the contact be-
tween XPA DBD and RPA70AB is mediated primarily by
residues in the zinc-binding motif. These results also sug-
gest that: (i) since the XPA DBD C-terminal 20 residues
required for DNA-binding activity are not required for in-
teraction with RPA70AB, further studies of the interaction
with RPA70AB can utilize either construct; (ii) RPA70AB
and DNA bind to the same region of XPA, but the sites
are sufficiently different to enable formation of the ternary
complex.
XPA DBD can interact with RPA70AB bound to ssDNA
Next, we asked if RPA70AB binding of ssDNA altered how
it interacts with XPA? The known RPA70AB high affin-
ity ssDNA substrate dC8 was used for these experiments. A
control experiment involving titration of dC8 into a solution
of 15N-enriched XPA98–219 revealed no effect on the spec-
trum (SupplementaryMaterials and Supplementary Figure
S3), as expected based on our previous study showing that
the XPA globular core does not bind ssDNA with any ap-
preciable affinity (23). In contrast, further titration of this
solution with RPA70AB resulted in a number of CSPs and
exchange broadened peaks (Figure 2E), which map primar-
ily to the N-terminal portion of XPA98–219, as we had ob-
served in the titration in the absence of dC8 (cf. Figure 2D
and F). Thus, XPA utilizes the same mode of binding with
RPA70AB whether or not RPA70AB is engaged on a ss-
DNA substrate.
To further analyze the interaction of XPA DBD and
RPA70AB, a reciprocal 2D heteronuclear 15N-1H NMR
titration of 15N-enriched RPA70AB bound to dC8 was per-
formed with unlabeled XPA. Since we had observed that
the binding site for RPA70AB did not involve residues 220–
229 and the shorter construct is much more soluble and
easy to titrate, XPA98–219 was used for this analysis. The
titration was performed in two phases, first dC8 was added
to the RPA70AB solution, then XPA98–219. The CSPs and
line broadening effects on 15N-RPA70AB upon binding ss-
DNA (Supplementary Materials and Supplementary Fig-
ure S4) closely matched those reported previously (51). Fur-
ther titration of XPA98–219 into 15N-enriched RPA70AB
with dC8 bound gives rise to CSPs and line broadening of a
subset of signals in the spectrum corresponding to residues
in and around the sites whereRPA70ABbinds ssDNA (Fig-
ure 3). The data show that, although theRPA70AB residues
perturbed upon binding of dC8 and XPA98–219 are in close
proximity and involve the same face of RPA70AB (Figure
3B), a ternary complex with independent binding sites can
be formed, i.e. XPADBDcan interact withRPA70ABwhile
RPA is engaged on its ssDNA substrate.
XPA DBD and RPA70AB form ternary complexes with both
5′ and 3′ model NER junction substrates
To further investigate the molecular basis and function of
the XPA DBD–RPA70AB interaction, we set out to deter-
mine the structure of a ternary complex with a substrate
that mimics the NERDNA bubble. Since this requires both
proteins to be bound to their respective portions of the
DNA substrate, the experiments were performed with the
full XPA DBD construct (XPA98–239). XPA is understood
to bind at one of the ss–ds junctions of the NER bubble,
Nucleic Acids Research, 2020, Vol. 48, No. 4 2179
Figure 2. NMR mapping of the RPA70AB-binding site in XPA DBD. (A and B) NMR titration of 15N-enriched XPA98–239 with RPA70AB. (A) Overlay
of the 900 MHz 15N-1H TROSY-HSQC spectrum of 15N-XPA98–239 in the absence (black) and presence (red) of RPA70AB in a 1:4 molar excess. (B)
Residues whose signals are perturbed in (A) mapped in red on the structure of the globular core of XPA. (C–F) NMR titrations of 15N-enriched XPA98–219
with RPA70AB in the absence (C,D) or presence (E,F) of ssDNA. (C) Overlay of the 900 MHz 15N-1H TROSY-HSQC spectrum of 15N-XPA98–219 in the
absence (black) and presence (red) of RPA70AB in a 1:4 molar excess. (D) Residues whose signals are perturbed in (C) mapped in red on the structure of
the globular core of XPA. (E) Overlay of the 900MHz 15N-1H TROSY-HSQC spectrum of 15N-XPA98–219 pre-equilibrated with dC8 in the absence (black)
and presence (red) of RPA70AB in a 1:4 molar excess. (F) Residues whose signals are perturbed in (E) mapped in red on the structure of the globular core
of XPA. The threshold for significance of CSPs and line broadening was set to the average of unperturbed resonances ±1 standard deviation. All spectra
were acquired in a buffer containing 20 mM Tris, pH 7.0, 150 mM KCl, 1 mM Tris (2-carboxyethyl) phosphine (TCEP) and 5% 2H2O at 25◦C.
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Figure 3. NMRmapping of XPA-binding site in RPA70AB. NMR titration of 15N-enriched RPA70ABwith XPA98–219 in the presence of dC8. (A) Overlay
of the 900 MHz 15N-1H TROSY-HSQC spectrum of 15N-RPA70AB pre-incubated with dC8 in the absence (black) and presence (red) of XPA98–219 in
a 1:4 molar excess. All spectra were acquired in a buffer containing 20 mM Tris, pH 7.0, 150 mM KCl, 1 mM Tris (2-carboxyethyl) phosphine (TCEP)
and 5% 2H2O at 25◦C. (B) Residues whose signals are perturbed in C are mapped in red on the structure of the globular core of XPA. The threshold for
significance was set to the average of unperturbed resonances ± 1.5 standard deviations.
but as noted above controversy exists as to which one (15).
RPA binds to and protects the undamaged strand of NER
substrates.
The first step in the design of the model NER bubble
substrate was to accommodate the known 5′-3′ orienta-
tion of RPA on ssDNA (11,52); RPA70AB is bound at
the 5′ end of the undamaged strand in the NER bubble,
which would place XPA DBD at the ss–dsDNA junction
3′ to the lesion. Hence, asymmetric Y-shaped DNA ss–ds
junction substrates were constructed with the 5′ arm and
duplex serving as the ss–ds junction for XPA DBD and
the 3′ ssDNA arm designed for RPA70AB (Supplemen-
tary Materials, Supplementary Figure S1A and B). SEC-
MALS was used to define an optimal substrate, combin-
ing retention on the SEC column and the molecular mass
of the complexes/sub-complexes derived from the MALS
profile. The specificity and homogeneity of complexes were
evaluated using these observations along with the measure-
ments of the extent of monodispersity of the top peak frac-
tion fromMALS and evaluation of the stoichiometry of the
complex by SDS-PAGE. First, different lengths of the du-
plex portion were tested, ranging from 4 to 16 bps (Sup-
plementary Materials and Supplementary Figure S1A). We
also tested structures causing a kink in the duplex, such as
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Table 1. Active residues identified from NMR data for HADDOCK
calculationsa
XPA DBDb RPA70AB
Contacts to DNA
Contacts to
RPA70AB Contacts to XPA DBD
99 101 211
131 103 218
142 104 219
143 106 239
152 110 264
153 112 268
156 115 275
167 116 290
168 120 292
174 127 387
175 131 388
176 146
202 174
205 219
206
208
211
212
216
217
218
221
222
225
228
232
aActive residues have significant CSPs or line broadening plus solvent ac-
cessible surface area of >50%.
bData for selecting the active residues for docking of DNA to XPA DBD
were reported previously Sugitani et al. (25).
a mismatch or gap, as well as capping the duplex with a 4xT
hairpin loop (SupplementaryMaterials and Supplementary
Figure S1A), but none of these modifications to the duplex
had any significant effect on formation or stabilization of
the ternary complex. The 5′ ssDNA overhang was initially
set to 4 nts based on our previous analysis and no bene-
fit was found by making it longer (25). We next tested the
length of the 3′ ssDNA overhang for RPA70AB. Assuming
that theminimal footprint of RPA70AB is 8 nt as seen in the
crystal structure (52,53), we designed substrates with over-
hangs of 10 or 12 nts (Supplementary Materials and Sup-
plementary Figure S1A) so that they contained a spacer be-
tween the RPA70AB-binding site and the ss–ds junction to
which XPA98–239 was bound. In the end, the optimal sub-
strate contained 10 bp of duplex with a 4 nt 5′ overhang
and a 12 nt 3′ overhang (SupplementaryMaterials and Sup-
plementary Figure S1B). SDS-PAGE of the complex shows
it is homogeneous and has the correct stoichiometric ra-
tio (Supplementary Materials Supplementary Figure S1B).
Once formed, this complex remains stable (does not degrade
or dissociate) for 1 week.
Having established the ability to form a stable ternary
complex with a substrate designed to mimic the 3′ ss–ds
DNA junction, we asked whether an equally stable com-
plex could be formed with a substrate that mimics the ss–
dsDNA junction 5′ to the lesion. These Y-shaped DNA ss–
ds junction substrates were designed with the 3′ arm and
the duplex serving as the ss–ds junction for XPA DBD and
the 5′ ssDNA arm for RPA70AB (Supplementary Mate-
rials and Supplementary Figure S1A and C). The critical
factor in thinking about such a substrate is that RPA70AB
would have to be inverted to retain its 5′-3′ orientation on ss-
DNA.We initially assumed that the complex formed would
be strained and less stable or that the RPA70AB arm would
need to be longer to accommodate its inverted orientation
with respect to XPADBD. In fact, neither of these assump-
tions proved to be correct as the substrate with a 10-nt 5′
arm (for RPA70AB) was formed cleanly, exhibited the cor-
rect stoichiometry (Supplementary Materials and Supple-
mentary Figure S1C) and remained intact for as many days
as the substrate with a 12-nt 5′ arm. This observation sug-
gested the possibility that models for XPA binding to both
the 3′ and 5′ ss–ds junction in the NER bubble are feasible.
Analysis by SEC-MALSof the ternary complexes formed
with the most stable 3′ and 5′ model NER substrates pro-
vides only limited insight. To further investigate how XPA
DBD and RPA70AB are arranged on the NER bubble and
compare these complexes in greater detail, small-angle x-ray
scattering (SAXS) data were acquired for both asymmet-
ric Y-shaped 3′ and 5′ model NER substrate complexes. In-
line coupled size-exclusion chromatography SAXS (SEC-
SAXS) was used to ensure optimal data quality (Supple-
mentaryMaterials and Supplementary Figure S2A–C). The
similarity in the SAXS data for the complexes is remark-
able. The SAXS profiles and linearity of the Guinier plots
(SupplementaryMaterials and Supplementary Figure S2B)
showed that both complexes were free of aggregation in
solution. The Kratky Plots revealed both complexes con-
tain globular domains and some flexible loops and/or link-
ers (Supplementary Materials and Supplementary Figure
S2C). Porod–Debye analysis, including values of 3.8 for
the Porod Exponent (Supplementary Materials and Sup-
plementary Figure S2D), indicated the ternary complexes
are stable and globular, and suggested that direct analysis
of the distance distribution function, P(r), is feasible for
both (Supplementary Materials and Supplementary Figure
S2E). The primary peak centered at ∼30 A˚ in both P(r)
functions is attributed to distance distributions within the
three ∼12 kDa globular domains: XPA98–219, RPA70A and
RPA70B. The small feature in P(r) at ∼50 A˚ is consistent
with distances between domains. The extension of theDmax
value out beyond 90 A˚ is consistent with the DNA duplex
extending beyond the portion of the substrate that is bound
by the two proteins and with the presence of residues at the
XPA DBD N- and C-termini that do not contact DNA.
XPA DBD and RPA70AB form similar compact ternary
complexes with model NER junction substrates
Structural models of the two different ternary complexes
were generated using a integrated structural approach that
combines a model of XPA DBD bound to a ss–ds DNA
junction, the X-ray crystal structure of RPA70AB with dC8
bound (53), NMR identification of the XPA DBD and
RPA70AB interaction interfaces, SAXS to define the shape
of the complexes, and computational docking and refine-
ment. For RPA, we started with the crystal structure of
RPA70AB in complex with dC8 (PDB: 1JMC). Because
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Figure 4. Comparison of structures of the XPA DBD–RPA70AB complexes bound to model NER bubble substrates. (A–C) Ribbon diagrams of the XPA
DBD–RPA70AB complex bound to the model 3′ junction DNA substrate with RPA70AB in orange, XPADBD in blue and DNA in green. (D–F) Ribbon
diagrams of the XPA DBD–RPA70AB complex bound to the model 5′ junction DNA substrate with RPA70AB in yellow, XPA DBD in dark blue and
DNA in green. The structures in (B) and (E) are aligned to the place RPA70AB in the same position, revealing the reversed orientation of XPA DBD. The
structures in (C) and (F) are aligned to place XPA DBD and the DNA in the same position, revealing the reversal in the orientation of RPA70AB.
there was no crystal structure for human XPA when the
study was undertaken, a high quality homology model was
generated in Modeller using as template the crystal struc-
ture of yeast XPA (Rad14 - 32% identity, 56% homology) in
complex with a lesion-containing duplex (PDB: 5A39). The
Rad14 structure lacks the residues corresponding to XPA
98–101 and 214–239, so these were generated computation-
ally and added onto the XPA homology model. Residues
214–234 were assigned helical conformation based on the
consensus of multiple secondary structure prediction pro-
grams (23), which has been confirmed by a recent crystal
structure (54). After the missing residues were added, the
entire structure was energy minimized. The DNA sequence
in the Rad14 crystal structure is different from that in our
substrates and the DNA structure is perturbed by the pres-
ence of the lesion. Consequently, the DNA was removed
and an ideal 10-mer duplex was docked to the protein in
HADDOCK using our previously published NMR CSPs
induced in XPA DBD by the binding of DNA (25) (Table
1).
The next step was to dock the XPA-DNA model to the
RPA70AB crystal structure. Up to this point, the XPA-
DBD model and the RPA70AB crystal structure were sep-
arate sub-complexes. To maximize the accuracy and effi-
ciency of docking at this early stage, rather than building
in the 4 nts required to attach the two DNA substrates, a
restraint was introduced to link the two sub-complexes to-
gether. For both models, an optimized restraint of 20 ± 3
A˚ was the most effective at ensuring the two distinct DNA
fragments remain connected while allowing full sampling of
configurations for docking. To ensure highest accuracy was
obtained, we adopted a strategy in which all experimental
data were utilized. Docking of the two structures was per-
formed using HADDOCK based on the NMR data (Table
1). The best scoringHADDOCK structures, which grouped
into distinct clusters, were then assessed for their fit to the
SAXS data. Next, the four missing nucleotides were built
into the structures and the fits to the SAXS data were re-
calculated. The final representative structure was the best
scoring HADDOCK structure within the best scoring clus-
ter, which also had the best  fit to the scattering curve (Fig-
ure 4A and C). Since the Porod analyses of the SAXS data
showed that both 3′ ss–ds junction and 5′ ss–ds junction
DNA complexes were well formed and globular, molecular
envelopes were calculated. For each complex, SUPCOMB
was then used to fit the best scoring structure into the SAXS
molecular envelope (Supplementary Materials and Supple-
mentary Figure S5). The excellent fit of the structures into
their respective molecular envelopes supports the accuracy
of both the 3′ and 5′ ss–ds junction DNA structural models.
The XPA DBD–RPA70AB complexes bound to the
model 3′ and 5′ ss–ds junction DNA NER substrates are
both quite compact and strikingly similar, near mirror im-
ages (Figure 4). In both complexes, the XPA–RPA interac-
tion interface involves the same face of RPA70AB adjacent
to the ssDNA-binding sites and the zinc-binding domain
of XPA DBD (Supplementary Materials; Supplementary
Figure S6 and Table S3). Both complexes have substantial
interfaces with 24 XPA/20 RPA residues and 783/795 A˚2
buried surface areas for the 3′ ss–ds junction substrate, and
29/25 residues and 856/899 A˚2 for the 5′ substrate. Both
complexes exhibit a mixture of hydrogen bonds (6, 9), salt
bridges (4, 3) and non-bonded contacts (69, 102). The sim-
ilarity extends to the specific residues engaged in the XPA–
RPA interface with approximately half being common, and
the remainder representing small shifts of only 1–3 residues
(Supplementary Materials, Supplementary Figure S6 and
Table S3). Thus, these structures lend further support for
the possibility that models for XPA binding to the 3′ or the
5′ ss–ds junction in the NER bubble are feasible.
Nucleic Acids Research, 2020, Vol. 48, No. 4 2183
Figure 5. Characterization and effect on NER of XPA mutations in the RPA70AB-binding interface. (A) Close up view of the six mutated sites depicted
on the final structural model. (B) MST measurement of DNA binding of XPA DBD wild-type and mutants. Data shown for XPA DBD, M2, M6 from
which KD values were determined of 5.7 M ± 0.4, 6.1 M ± 0.3, 6.0 M ± 0.4 and 13.0 M ± 3.1, respectively. Data are also shown for the negative
control XPAK222E. Error bars represent standard deviations from at least three measurements. (C) EMSA analysis of DNA binding of a 5′-FAM-labeled
three-way junction substrate with WT or mutant XPA on an 8% native polyacrylamide gel. Protein concentration and the positions of the unbound DNA
(free DNA), XPA-bound DNA (protein-DNA) are indicated. (D) In vitroNER activity assay for the wild-type and mutant proteins. A plasmid containing
a site-specific Cis-Pt adduct was incubated with either HeLa whole cell extract (M) or XPA-deficient cell extract and recombinant purified WT or mutant
XPA. The excision products were detected by annealing to complementary oligonucleotide with 4G overhang, which was used as a template for a fill-in
reaction with [-32P]dCTP. The asterisk indicates background bands resulting from the method used to detect the excised NER fragments. These arise
from incubation of the plasmid-containing substrate with Sequenase. As can be seen from the lanes in XPA-deficient cell extracts incubated without XPA
protein, they are not dependent on NER. A previous report showed that application of this assay in a quantitative manner is possible even when such
non-specific cleavage bands present (63). The NER products were analyzed on 14% denaturing PAGE gel and visualized on a phosphorimager. Reaction
times and identity of the proteins and location of NER and non-specific bands are indicated. (E) Close up view of the overlay of 15N-1H HSQC NMR
spectra of 15N-enriched XPA DBD and wild-type (WT), M2 and M6 XPA DBD in the presence of a 4-fold molar excess of RPA70AB.
Mutations in XPA DBD inhibit RPA70AB interaction with-
out altering binding of DNA
To test the structural models and generate mutants
to probe the functional importance of the interaction
between XPA DBD and RPA70AB, four XPA DBD
mutants were designed to perturb the interaction with
RPA70AB: E106K, F112A, E106K+F112A (M2) and
D101N+E106K+K110E+E111K+F112A+D114N (M6)
(Figure 5A). E106K and F112A were selected as single
mutants because they are in the binding interface in the
model and they exhibit the largest perturbations of their
NMR signals upon binding to RPA70AB. E106 was just
one of the significant number of charged residues in the
binding interface and based on initial results for E106K
andM2, knowledge that electrostatic forces are long-range,
and past experience with multi-site mutations, four more
charge reversal mutations were added to the design of
M6 with the goal of generating a mutant that would
substantially inhibit binding to RPA70AB. The mutations
were incorporated into the XPA DBD construct and their
effects on the structure, DNA-binding affinity and ability
to interact with RPA70AB were determined. The results
for the single-site and M2 mutant were similar, most
importantly with the respect to the extent of impairment of
interaction with RPA70AB, so in the following we describe
only the data for the M2 and M6.
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The effect of mutation on the structure of XPADBDwas
assessed by circular dichroism (CD) and NMR. The CD
spectra of M2 andM6 were very similar to that of the wild-
type protein (SupplementaryMaterials and Supplementary
Figure S7A), showing that the two constructs contain the
same distribution of secondary structure (55). The 2D 15N-
1H HSQC NMR spectra provide insight into the tertiary
structure of the protein. Comparison of the spectra of M2,
M6 and the wild-type protein reveal the expected trends for
multi-mutations that do not perturb the 3D structure: the
distribution of peaks is the same in all three spectra but a
number of peaks are shifted relative to wild-type as a re-
sult of changes in chemical structure of the side chains and
small structural adjustments (SupplementaryMaterials and
Supplementary Figure S7B–D). Microscale thermophore-
sis (MST) was used to measure the DNA-binding affinity of
M2 and M6 using a fluorescein-labeled DNA substrate as
reported previously (25) (Figure 5B). The K222E mutant,
known to have weaker DNA-binding affinity, was used as
a negative control. The KD of wild-type, M2 and M6 de-
rived from these data was 5.7 M ± 0.4, 6.1 M ± 0.3 and
6.0 M ± 0.4, respectively, revealing there were no statisti-
cally significant differences in DNA-binding affinity induce
by the mutations (Figure 5B). The value for wild-type XPA
DBD is similar to that reported previously (3.5 M ± 0.2)
(25).
The XPA DBD mutants were then tested for interac-
tion with RPA70AB by comparing NMR CSPs induced by
the wild-type and mutant proteins (Supplementary Mate-
rials and Supplementary Figure S8). Although the NMR
chemical shift perturbations over the course of a titration
can be used to extract binding affinities in the micromo-
lar to millimolar range, direct quantitative comparisons of
Kd values is not possible in this case because the affinity is
weak and cannot bemeasured accurately. However, because
the residues exhibiting CSPs and the nature of the shifts of
peaks is the same for M2, M6 and wild-type DBD, a com-
parison of the relative amount of CSP at a given stoichiom-
etry can be used to generate a qualitative assessment of the
relatively affinities of the three proteins. Overlays of two
representative peaks showing CSPs induced by identical
amounts of wild-type, M2 and M6 reveal that the M2 peak
for the RPA70AB bound state is close to but not shifted
as far as wild-type, and that the M6 peak is shifted con-
siderably less than M2 (Figure 5E). Thus, M2 and M6 have
progressively weaker affinity than wild-type XPADBD. To-
gether, the structural and biophysical data show that theM2
and M6 mutations achieve our design goal of generating
mutants whose sole effect is impairing the binding of XPA
DBD to RPA70AB.
Disruption of the XPA DBD–RPA70AB interaction dimin-
ishes NER activity
Since theM2 andM6mutations have been shown to impair
the physical interaction of XPA DBD with RPA70AB, we
next tested how they influence NER activity. The standard
approach used for these studies is to first perform an EMSA
assay to determine if there are any effects from the muta-
tions on the DNA-binding properties of the protein (Fig-
ure 5C). Interestingly, the M2 mutation appears to have no
significant effect on the DNA-binding affinity of full-length
XPA, but the addition of the four additional charge rever-
sal mutations in the M6 mutant results in a mild, but dis-
cernable reduction in affinity and appearance of a second
band in the EMSA. Interestingly, this observation contrasts
with the absence of an effect in the quantitativeMST analy-
sis. While we are uncertain as to the origin of this difference,
we note that the MST analysis was performed with a model
NER substrate, whereas the EMSA, which used a fully du-
plexed three-way DNA junction, was not. Moreover, it is
clear that the M6 XPA mutant still binds DNA with appre-
ciable affinity.
The NER assay involved monitoring the excision of a
damaged-containing oligonucleotide from a plasmid incu-
bated in cell-free extracts from XPA-deficient cells com-
plemented with XPA wild-type or mutant proteins, as re-
ported previously (9). A plasmid containing a site-specific
1,3-cisplatin intrastrand crosslink was used for these exper-
iments. Repair of the plasmid is evident over time for the
wild-type protein (Figure 5D). The mutant E106K, which
did not inhibit the interaction with RPA70AB, was used
as a positive control and had comparable levels of activ-
ity as the wild-type protein. In contrast, M2 exhibited re-
duced levels of repair and M6 had a more substantial effect
on NER activity, proportional to the extent of reduction in
their ability to bind toRPA70AB (Figure 5E). Although the
effect on NER observed for the M6 mutations may have an
additional contribution (63) from the modest reduction in
DNA-binding affinity. Overall, these results strongly sup-
port the proposal that the interaction of XPA DBD with
RPA70AB is functionally relevant and required for effective
repair of bulky DNA adducts by NER.
DISCUSSION
Comparison of different models for DNA binding by XPA
Although structures of the globular core of XPA were
determined almost 20 years ago, the details of how XPA
binds DNA substrates remained unknown until the
structure of the globular core of the yeast homolog of
XPA, Rad14, was determined in complex with damaged
DNA (56). However, concerns arose about whether or
not these structures were broadly applicable to DNA
binding by XPA, for example in the context of its primary
function in NER (25). One concern is that all Rad14–DNA
structures were determined for DNA duplexes contain-
ing C8-acetylated deoxyguanosine(dG) bulky-adduct
lesions [acetylaminophenyl(dG-AAB), acetylamino-
naphthyl(dG-AAN), acetylaminoanthryl(dG-AAA) and
acetyl-aminopyrenyl(dG-AAP) phosphoramidite], which
XPA binds with extraordinary high affinity, substantially
higher than undamaged DNA and duplexes containing a
large number of other lesions (56–58). A second concern
is two molecules of the Rad14 globular core are bound to
the end of the lesion-containing duplex. The interpretation
of the first structures suggested Rad14 directly recognizes
damage, even though the protein does not directly contact
the lesion (56). More recently, the high affinity binding of
Rad14 was attributed to an intrinsic kink in the duplex
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induced by the lesion (58). Thus, Rad14 binding appears
to correlate with bent DNA duplex structure, as had been
found in earlier studies (6).
XPA was discovered and has been extensively studied as
a critical factor for NER. Consequently, the relevance of
the structure of Rad14 bound to lesion-containing duplex
DNA was questioned because XPA is recruited to NER
machinery only after damaged duplex DNA is unwound
by TFIIH (8). Moreover, since it is generally understood
that the NER machinery contains only a single molecule
of XPA, simultaneous binding of two Rad14 molecules to
the damaged DNA was difficult to fit into a NER model.
Nevertheless, the Rad14 structural data provide a basic un-
derpinning for how XPA interacts with DNA.
We have previously shown that full binding affinity for
ss–ds junction NER substrates requires not only the XPA
globular core but also a helical C-terminal extension from
the core (23,25). In our structures, the helical extension
binds the duplex while the globular core interacts at the
ss/dsDNA junction (Figure 4A and D). Remarkably, even
though the helical extension is missing and two Rad14
molecules bind to one duplex in the Rad14 crystal struc-
ture, there are substantial similarities in how XPADBD in-
teracts with the DNA substrate (Supplementary Materials
and Supplementary Figure S9). Residues H258 and F262 in
Rad14 extend out from the core and are proposed to func-
tion as an anchor point for the unwound base pairs of the
damaged duplex (56). In the context of NER, the homol-
ogous XPA residues, H171 and W175, are seen to form a
wedge between the two strands and stabilize the ss–ds junc-
tion (Supplementary Materials and Supplementary Figure
S9B). However, in contrast to the structures of Rad14 in
complex with dG lesion-containing duplexes, our structure
shows that XPA requires neither a kink in the DNA nor a
lesion to productively interact with the DNA substrate. As
we noted previously, these differences in how XPA interacts
with different DNA lesion-containing substrates may cor-
relate to XPA functions in repair pathways outside of NER
(15).
XPA binding to RPA70AB and the 5′ versus 3′ ss–ds DNA
junction
XPA functions in conjunction with RPA as the scaffold for
the NER pre-incision complex. The co-localization of the
two proteins ismediated by an interaction betweenRPA32C
and a motif in the disordered XPA N-terminal domain
(19). However, it is difficult to see how their activity would
be coordinated by this interaction. RPA32C is tethered to
the DNA substrate binding apparatus by a 33-residue long
flexible linker (59). Moreover, the RPA32C-binding motif
on XPA is located within the flexible, disordered XPA N-
terminal domain,>50 residues from the XPADBD (19,29).
We propose that the critical factor enabling the coordina-
tion of XPA and RPA is the direct physical interaction be-
tween XPA DBD and RPA70AB, as this interaction is spa-
tially proximate to the binding of both proteins to the NER
bubble.
Our results resolve the controversy over which part of
XPA DBD mediates the interaction with RPA70AB. Our
comprehensive analysis of two XPA constructs and of the
Figure 6. Schematic diagramofXPAandRPAon anNERbubble showing
how XPA can be bound to the 3′ ss–ds junction yet still be close to the 5′
ss–ds junction. The lesion is indicated by a star. A two-headed arrow is
drawn to show that when the DNA substrate is not extended linearly, the
3′ ss–ds junction can be close enough to the 5′ ss–ds junction for XPA to
span the gap.
effect of DNA substrates shows that RPA70AB binds pri-
marily to the N-terminal zinc-binding motif (residues 98–
125) region, confirming the suggestionmade from anNMR
titration of XPA98–219 with RPA70AB in the absence of
DNA (31). The competing proposal, that XPA residues
153–176 are important (33), was based on the loss of bind-
ing for a construct in which these residues were deleted. In
examining the structure of the XPA DBD, it is clearly evi-
dent that this deletion will greatly destabilize the structure.
Hence, loss of interaction with RPA was almost certainly
due to the inability of the XPA DBD to fold properly, not
loss of the critical region for interaction. This issue high-
lights the inherent risk of interpreting the effects of muta-
tions in the absence of proper controls to test for perturba-
tions of structure and/or stability.
The exact location of XPA within NER complexes has
not yet been firmly established. It is commonly agreed that
XPA binds at the edge of theNERbubble, i.e. at ss–dsDNA
junctions (15,60). However, some models place XPA at the
junction 3′ to the lesion whereas others 5′ to the lesion. We
began our analysis using a substrate that mimics RPA70AB
and XPA binding at the junction 3′ from the lesion, because
it readily accommodates the known 5′ to 3′ polarity of RPA
(11,51). Studies by Krasikova et al. on binding of RPA to a
range of substrates point to a possible preference for XPA
binding to the 5′ junction, but their data were not unam-
biguous and firm conclusions could not be drawn (14,61).
A structure has recently been determined of the complex
of TFIIH and XPA bound to a Y-shaped DNA substrate
mimicking a 5′ junction (62). The primary rationale for
models positioning XPA on the ss–dsDNA junction 5′ from
the lesion is the need for close proximity to NER nuclease
XPF/ERCC1, which incises DNA 5′ from the lesion, and
is known to interact with XPA (16). However, these models
are drawn from the perspective of linear 2D representations.
Upon examination of 3Dmodels as shown schematically in
Figure 6, it is clear that XPA bound at the 3′ ss–ds junction
would still be able to contact the 5′ junction since its XPF-
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ERCC1 binding motif resides in the disordered, N-terminal
domain (9).
To test if one, the other or both 3′ and 5′ ss–ds junctions
could be accommodated while retaining the critical interac-
tion of XPADBDwith RPA70AB, we obtained experimen-
tal data and generated structural models for complexes with
substratesmimicking both junctions. Stable complexes were
formed using asymmetric Y-shaped ss–ds substrates of the
same size that differed only in the 3′ versus 5′ positioning of
the short and long arms, and the corresponding complexes
were found to be remarkably similar to each other. The two
complexes are effectively mirror images, i.e. flipped by 180◦
relative to one other with the zinc-binding region of XPA
DBD rotated with respect to the RPA70AB interface (Fig-
ure 4B andE; SupplementaryMaterials and Supplementary
Figure S6). The symmetric relationship is also evident when
aligning the structures to the XPA DBD, which shows that
the orientation of the RPA70A and RPA70B domains is in-
verted with respect to the XPA DBD as a result of the 5′-3′
polarity of RPA on ssDNA (Figure 4C and F). The ability
to form stable complexes with both substrates suggests the
possibility that XPA could bind at either of the two different
ss–dsDNA junctions in the bubble. If this were to happen, it
would presumably occur at different points in the trajectory
of NER.
Implications for coordinated XPA–RPA function in NER
The spatial arrangement of XPA and RPA is critical for
the correct positioning of the essential nucleases XPF and
XPG on the NER bubble and formation of a properly func-
tioning pre-incision complex. XPA binding to RPA70 was
previously shown to be required for NER (34). Our data
show that defects even in the weaker of the two XPA–
RPA contacts, between XPA DBD and RPA70AB, cause
a fundamental dysfunction of nucleotide excision repair in
cell extracts (Figure 5D). Structure-based design of muta-
tions enabled us to progressively weaken this interaction,
from modest effects for E106K/F112A to nearly eradicat-
ing NER by the addition of four more, electrostatic-based
mutations. Misalignment of the XPA DBD–RPA70AB in-
teraction may affect the assembly of the entire NER ma-
chinery, which can form the basis for XPA-related disease.
In this vein, we note the F112C mutation has been re-
ported in the PanCan Atlas as a cancer-associated muta-
tion (TCGA, PanCan Atlas: https://portal.gdc.cancer.gov/
genes/ENSG00000136936).
Structural and functional analysis of theXPADBDbind-
ing to RPA70AB has revealed an important function in
NER for this interaction, even though the affinity is rela-
tively weak in the micromolar range. Our results have re-
solved the controversy over exactly where the two domains
interact. They also provided strong evidence in support of
only a single XPA molecule being involved in binding of
DNA substrates and suggest that XPA may in fact bind to
both the 3′ or 5′ ss–ds junction in NER complexes. Beyond
providing data to predict the molecular basis for dysfunc-
tion of disease-associated XPA mutations, the structural
characterization of the interaction between XPA DBD and
RPA70AB also provides a starting point for small molecule
discovery and subsequent evaluation of the therapeutic po-
tential of targeting XPA function.
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